-
(Z)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-1-(3,3-difluoroazetidin-1-yl)prop-2-en-1-one
-
BD6302611421919-75-698%
-
¥679.010mg
-
(2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E)-17-Ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-19-((2S,3S)-3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-8-oxononadeca-2,10,12,16,18-pentaenoic acid
-
BD13614687081-35-498%
-
¥2119.010mg
-
(Z)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acrylohydrazide
-
BD6302131392136-43-498%
-
¥1510.050mg
-
(Z)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide
-
BD3183281393477-72-998%
-
¥1340.0100mg
-
(E)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-2-(pyrimidin-5-yl)acrylamide
-
BD7647161642300-52-498%
-
¥757.025mg
-
PKF050-638
-
BD01180199528893-52-998%
-
¥
-
(Z)-2-(2-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)vinyl)-1,3,4-oxadiazole
-
BD2924051388841-50-695% mix TBC as stabilizer
-
¥3472.01mg
-
(2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E)-6-Hydroxy-3,5,7,9,11,15,17-heptamethyl-19-((2S,3S)-3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-8-oxononadeca-2,10,12,16,18-pentaenoic acid
-
BD0112260187081-36-599+%
-
¥
-
Kpt-185
-
BD6301321333151-73-798+%
-
¥7192.0100mg
-
1-((6-Chloro-5-(trifluoromethyl)pyridin-2-yl)amino)-3-((3,3-dimethylbutoxy)methyl)-4-methyl-1H-pyrrole-2,5-dione
-
BD011366121076235-04-598%
-
¥8500.0100mg
-
CRM1-IN-2
-
BD0227843198%
-
¥
-
LFS-1107
-
BD025099751799330-91-898%
-
¥
-
CRM1 degrader 1
-
BD023026332986647-41-898%
-
¥
-
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxychromenylium chloride
-
BD15806528-58-598% HPLC
-
¥103.05g
-
CRM1-IN-1
-
BD0230988098%
-
¥
-
(E)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide
-
BD3297781421923-86-595%
-
¥6440.0250mg
-
Eltanexor Z-isomer
-
BD7647171642300-78-498+%
-
¥3820.05mg